Korro Bio, Inc. (KRRO) stock
KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.32−0.39 (-3.07%)
Close on Nov 17, 2026Market cap $181.42MP/E –Yield –
Korro Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Korro Bio's total debt was $0 at Sep 30, 2023. For fiscal 2022 it was $10.00M, up 1100.5% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $10.00M | +1100.5% |
| FY2021 | Dec 31, 2021 | $833.00K | +362.8% |
| FY2019 | Dec 31, 2019 | $180.00K | -48.4% |
| FY2018 | Dec 31, 2018 | $349.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $11.67M | +250.0% |
| Q4 FY2022 | Dec 31, 2022 | $10.00M | +1100.5% |
| Q3 FY2022 | Sep 30, 2022 | $8.33M | +4529.4% |
| Q2 FY2022 | Jun 30, 2022 | $5.83M | +2527.5% |
| Q1 FY2022 | Mar 31, 2022 | $3.33M | +855.0% |
| Q4 FY2021 | Dec 31, 2021 | $833.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $180.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $222.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $349.00K | – |
See a number that looks wrong?